Abstract
Cats receiving 0.15 mg/kg of reserpine, i.p., had rapid eye movement (REM) sleep suppressed for two days and showed increased ponto-geniculo-occipital (PGO) spikes in waking and slow-wave sleep; these effects were not reversed by administration of dopa. Reserpine (0.125 mg) given intraventricularly, however, significantly increased REM sleep and did not change the frequency of PGO spikes in waking and slow-wave sleep. The differences in sleep characteristics seen between i.p. and central administration of reserpine are probably due to (a) the marked peripheral autonomic side effects accompanying reserpine, i.p., and (b) the much smaller central depletion of brain monoamines following intraventricular reserpine. Also, the correspondance between the regional levels of brain biogenic amines and the occurrence of the sleep states is poor since REM and slow-wave were normal on the third day after reserpine, i.p., while norepinephrine and serotonin levels were depressed by about 50% at that time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Coulter, J. D., Lester, B. K., Williams, H. L.: Reserpine and sleep. Psychopharmacologia (Berl.) 19, 134–147 (1971).
Delorme, F., Jeannerod, M., Jouvet, M.: Effects remarquables de la réserpine sur l'activité EEG phasique ponto-geniculo-occipitale. C.R. Soc. Biol. (Paris) 159, 900–903 (1965).
Dement, W., Zarcone, V., Ferguson, J., Cohen, H., Pivik, T., Barchas, J.: Some parallel findings in schizophrenic parients and serotonin depleted cats. In: Schizophrenia: Current concepts and research. D. V. S. Sankar, ed., pp. 775–811. Hicksville, New York: PJD Publications 1969.
Gal, E. M., Millard, S. A.: The relevancy of changes in cerebral 5-hydroxytryptamine to reserpine produced sedation. Biochem. Pharmacol. 17, 2193–2203 (1968).
Gottesmann, C.: Reserpine et vigilance chez le rat. C. R. Soc. Biol. (Paris) 160, 2056–2061 (1966).
Hartmann, E.: Reserpine: Its effect on the sleep-dream cycle in man. Psychopharmacologia (Berl.) 9, 242–247 (1966).
Hishikawa, Y., Nakai, K., Ida, H., Kaneko, Z.: The effects of imipramine, desmethylimipramine and chlorpromazine on the sleep-wakefulness cycle of the cat. Electroenceph. clin. Neurophysiol. 19, 518–521 (1965).
Hoffman, J. S., Domino, E.: Comparative effects of reserpine on the sleep cycle of man and cat. J. Pharmacol. exp. Ther. 170, 190–198 (1969).
Jouvet, M.: Insomnia and decrease of cerebral 5-hydroxytryptamine after destruction of the raphé system in the cat. Advanc. Pharmacol. 6 B, 265–279 (1968).
Jouvet, M., Vimont, P., Delorme, F.: Suppression élective du sommeil paradoxal chez le Chat par les inhibiteurs de la monoamineoxydase. C. R. Soc. Biol. (Paris) 159, 1595–1599 (1965).
Karczmar, A. G., Longo, V. G., Scotti De Carolis, A.: A pharmacological model of paradoxical sleep: The role of cholinergic and monoamine systems. Physiol. Behav. 5, 175–182 (1970).
King, C. D.: The pharmacology of rapid eye movement sleep. Advanc. Pharmacol. Chemother. 9, 1–91 (1971).
Koller, W. C., Berry, C. A.: Effects of tetrabenazine and syringosingopine on sleep rhythm in the cat. Pharmacologist 13, 305 (1971).
Maickel, R. P., Cox, R. H., Saillant, J., Miller, F. P.: A method for the determination of serotonin and norepinephrine in discrete areas of rat brain. Int. J. Neuropharmacol. 7, 275–281 (1968).
Matsumoto, J., Jouvet, M.: Effects de réserpine, DOPA et 5 HTP sur les deux états de sommeil. C. R. Soc. Biol. (Paris) 158, 2137–2140 (1964).
Morgane, P. J., Stern, W. C.: Relationship of sleep to neuroatomical circuits, biochemistry, and behavior. Ann. N. Y. Acad. Sci. 193, 95–111 (1972).
Orzeck, A., Barbeau, A.: Interrelationships among dopamine, serotonin and acetylcholine. In: l-Dopa and Parkinsonism. A. Barbeau and F. H. McDowell, eds., pp. 88–94. Philadelphia: F. A. Davis Comp. 1970.
Reite, M., Pegram, G. V., Stephens, L. M., Bixler, E. C., Lewis, O. L.: The effect of reserpine and monoamine oxidase inhibitors on paradoxical sleep in the monkey. Psychopharmacologia (Berl.) 14, 12–17 (1969).
Sterman, M. B., Knauss, T., Lehmann, M. D., Clemente, C. D.: Circadian sleep and waking patterns in the laboratory cat. Electroenceph. clin. Neurophysiol. 19, 509–517 (1965).
Tabushi, K., Himwich, H. E.: The acute effects of reserpine on the sleep-wakefulness cycle in rabbits. Psychopharmacologia (Berl.) 16, 240–252 (1969).
Thompson, J. H., Spezia, C. A., Angulo, M.: Fluorometric detection of serotonin using o-Phthaldialdehyde: An improvement. Experientia (Basel) 15, 327–329 (1970).
Tissot, R.: The effect of certain drugs on the sleep cycle in man. In: Progress in brain research. Sleep mechanisms. K. Akert, C. Bally and J. P. Schadé, eds., vol. 18, pp. 175–177. Amsterdam: Elsevier 1965.
Winer, B. J.: Statistical principles in experimental design. New York: McGraw-Hill Book 1962.
Author information
Authors and Affiliations
Additional information
This study was supported by grants MH-02211, MH-10625 and RR-05528.
Rights and permissions
About this article
Cite this article
Stern, W.C., Morgane, P.J. Effects of reserpine on sleep and brain biogenic amine levels in the cat. Psychopharmacologia 28, 275–286 (1973). https://doi.org/10.1007/BF00429308
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00429308